Εμφάνιση απλής εγγραφής

dc.contributor.authorFelekkis, Kyriacos N.en
dc.contributor.authorKoupepidou, P.en
dc.contributor.authorKastanos, E.en
dc.contributor.authorWitzgall, R.en
dc.contributor.authorBai, C. -Xen
dc.contributor.authorLi, L.en
dc.contributor.authorTsiokas, L.en
dc.contributor.authorGretz, N.en
dc.contributor.authorConstantinou-Deltas, Constantinos D.en
dc.creatorFelekkis, Kyriacos N.en
dc.creatorKoupepidou, P.en
dc.creatorKastanos, E.en
dc.creatorWitzgall, R.en
dc.creatorBai, C. -Xen
dc.creatorLi, L.en
dc.creatorTsiokas, L.en
dc.creatorGretz, N.en
dc.creatorConstantinou-Deltas, Constantinos D.en
dc.date.accessioned2019-11-04T12:50:33Z
dc.date.available2019-11-04T12:50:33Z
dc.date.issued2008
dc.identifier.issn1471-2369
dc.identifier.urihttp://gnosis.library.ucy.ac.cy/handle/7/53068
dc.description.abstractBackground. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is characterized by the formation of multiple fluid-filled cysts that destroy the kidney architecture resulting in end-stage renal failure. Mutations in genes PKD1 and PKD2 account for nearly all cases of ADPKD. Increased cell proliferation is one of the key features of the disease. Several studies indicated that polycystin-1 regulates cellular proliferation through various signaling pathways, but little is known about the role played by polycystin-2, the product of PKD2. Recently, it was reported that as with polycystin-1, polycystin-2 can act as a negative regulator of cell growth by modulating the levels of the cyclin-dependent kinase inhibitor, p21 and the activity of the cyclin-dependent kinase 2, Cdk2. Methods. Here we utilized different kidney cell-lines expressing wild-type and mutant PKD2 as well as primary tubular epithelial cells isolated from a PKD transgenic rat to further explore the contribution of the p21/Cdk2 pathway in ADPKD proliferation. Results. Surprisingly, over-expression of wild-type PKD2 in renal cell lines failed to inactivate Cdk2 and consequently had no effect on cell proliferation. On the other hand, expression of mutated PKD2 augmented proliferation only in the primary tubular epithelial cells of a rat model but this was independent of the STAT-1/p21 pathway. On the contrary, multiple approaches revealed unequivocally that expression of the cyclin-dependent kinase inhibitor, p57KIP2, is downregulated, while p21 remains unchanged. This p57 reduction is accompanied by an increase in Cdk2 levels. Conclusion. Our results indicate the probable involvement of p57KIP2 on epithelial cell proliferation in ADPKD implicating a new mechanism for mutant polycystin-2 induced proliferation. Most importantly, contrary to previous studies, abnormal proliferation in cells expressing mutant polycystin-2 appears to be independent of STAT-1/p21. © 2008 Felekkis et alen
dc.description.abstractlicensee BioMed Central Ltd.en
dc.sourceBMC Nephrologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-51649086198&doi=10.1186%2f1471-2369-9-10&partnerID=40&md5=051198abf543378fd313cb2ca37eed42
dc.subjectarticleen
dc.subjecthumanen
dc.subjectHumansen
dc.subjectkidney polycystic diseaseen
dc.subjectcell proliferationen
dc.subjectgene expression regulationen
dc.subjectnonhumanen
dc.subjectpathologyen
dc.subjectsignal transductionen
dc.subjectmetabolismen
dc.subjecthuman cellen
dc.subjectgene expressionen
dc.subjectAnimalsen
dc.subjectanimalen
dc.subjectanimal cellen
dc.subjectbiosynthesisen
dc.subjectgeneticsen
dc.subjectphysiologyen
dc.subjectgene mutationen
dc.subjectgene overexpressionen
dc.subjectprotein p21en
dc.subjectEpithelial Cellsen
dc.subjectenzyme inhibitionen
dc.subjectenzyme activationen
dc.subjectgenetic transfectionen
dc.subjectAnimals, Genetically Modifieden
dc.subjecttransgenic animalen
dc.subjectamino acid substitutionen
dc.subjectmutant proteinen
dc.subjectPolycystic Kidney, Autosomal Dominanten
dc.subjectcell divisionen
dc.subjectautosomal dominant inheritanceen
dc.subjectmissense mutationen
dc.subjectMutation, Missenseen
dc.subjectpolycystinen
dc.subjectpolycystin 1en
dc.subjectTRPP Cation Channelsen
dc.subjectTransfectionen
dc.subjectraten
dc.subjectRatsen
dc.subjecthybrid proteinen
dc.subjectRecombinant Fusion Proteinsen
dc.subjectpolycystin 2en
dc.subjectCdk2 protein, raten
dc.subjectcell lineen
dc.subjectcell membrane potentialen
dc.subjectcell strain HEK293en
dc.subjectcyclin dependent kinase 2en
dc.subjectcyclin dependent kinase inhibitor 1Cen
dc.subjectCyclin-Dependent Kinase 2en
dc.subjectCyclin-Dependent Kinase Inhibitor p57en
dc.subjectepithelium cellen
dc.subjectkidney tubuleen
dc.subjectkidney tubule cellen
dc.subjectKidney Tubulesen
dc.subjectMembrane Potentialsen
dc.subjectp21 activated kinaseen
dc.subjectp21-Activated Kinasesen
dc.subjectPak1 protein, raten
dc.subjectpatch clampen
dc.subjectPatch-Clamp Techniquesen
dc.subjectpoint mutationen
dc.subjectpolycystic kidney disease 2 proteinen
dc.subjectprotein p57en
dc.subjectSTAT1 proteinen
dc.subjectStat1 protein, raten
dc.subjectSTAT1 Transcription Factoren
dc.subjecttransgenic raten
dc.titleMutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2en
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/1471-2369-9-10
dc.description.volume9
dc.author.facultyΣχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences
dc.author.departmentΤμήμα Βιολογικών Επιστημών / Department of Biological Sciences
dc.type.uhtypeArticleen
dc.description.notes<p>Cited By :11</p>en
dc.source.abbreviationBMC Nephrol.en
dc.contributor.orcidConstantinou-Deltas, Constantinos D. [0000-0001-5549-9169]
dc.gnosis.orcid0000-0001-5549-9169


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής